Log In
Print this Print this

ON 123300

  Manage Alerts
Collapse Summary General Information
Company Onconova Therapeutics Inc.
DescriptionInhibitor of cyclin dependent kinase 4 (CDK4) and NUAK family SNF-like kinase 1 (NUAK1; ARK5)
Molecular Target Cyclin dependent kinase 4 (CDK4) ; NUAK family SNF-like kinase 1 (NUAK1) (ARK5)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationSolid tumors
Indication DetailsTreat CDK4/6 overactive tumors
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today